Chromium(III) chelate of deoxyalliin and its bioactivity

Chromium(III) chelate of deoxyalliin has been prepared and characterized using physical and spectral means and its bioactivity has been determined. FT-IR showed the coordination of amino and carboxylate groups of the amino acid to the metal. Elemental analysis, mass spectrometry, and TGA suggested its formula to be Cr(C₆H₁₀O₂NS)₃. UV-Vis spectroscopy and magnetic moment proved octahedral geometry. Conductivity measurement showed it to be a non-ionic compound. Bioactivity analysis showed that the complex is active against Gram-positive and Gram-negative bacteria and yeast as well.     

Identification of novel vaccine candidates against carbapenem resistant Klebsiella pneumoniae: A systematic reverse proteomic approach

Klebsiella pneumoniae is declared as antibiotic resistant by WHO, with the critical urgency of developing novel antimicrobial therapeutics as drug resistance is the second most dangerous threat after terrorism. Besides many attempts still, there is no effective vaccine available against K. pneumoniae. By utilizing all the available proteomic data we prioritized the novel proteins ideal for vaccine development using bioinformatics tools and techniques. Among the huge data, eight proteins passed all the barriers and were considered ideal candidates for vaccine development. These include: copper silver efflux system outer membrane protein (CusC), outer membrane porin protein (OmpN), Fe⁺⁺ enterobactin transporter substrate binding protein (fepB), zinc transporter substrate binding protein (ZnuA), ribonuclease HI, tellurite resistant methyltransferase (the B), and two uncharacterized hypothetical proteins (WP_002918223 and WP_002892366). These proteins were also subjected to epitope analysis and were found best for developing subunit vaccine against K. pneumoniae. The study shows that the potential vaccine targets are sufficiently efficient being virulent, of outer membranous origin and can be proposed for the DNA third-generation vaccines development that would help to cope up infections caused by multidrug-resistant K. pneumoniae.     

MoS2@ZnxCd1-xS增强可见光诱导产氢性能同时降解抗生素废水:固溶体策略助力光催化（英文）

随着工业化进程的加快,能源的需求亦随之增长.以传统不可再生的化石燃料为主体的能源结构,虽然可以满足日常能源需求,但是使用后其排放的氮氧化物,硫氧化物以及CO2温室气体将会对人类的环境造成污染.因此,开发清洁可持续的新型能源成为重要的研究方向之一.氢能作为一种可持续能源,具有高热值、零排放等优点,而光催化粉末体系制氢则具有低成本,低污染等优势.因此,光催化制氢有望成为未来氢能重要的生产方式之一.然而,由于目前关于光催化制氢的研究大多集中于牺牲剂体系,例如醇类及醇胺类体系.传统牺牲剂体系作为探索光催化制氢的作用机制是很有效的,但是具体到未来工业化进程中,其经济性还需进一步的提高,且其中甲醇、乙醇等本身也可作为一种燃料使用.因此,开发廉价的牺牲剂体系,也成了未来工业化进程中的一个重要方面.本文选用MoS2@ZnxCd1-xS作为催化剂,以抗生素废水作为牺牲剂,在可见光照射下实现产氢的同时,降解阿莫西林抗生素废水,相比于单独的MoS2@ZnS及MoS2@CdS体系,性能明显的提高.通过扫描电镜与元素分布测试证明了各个元素的存在及分布.XRD结果表明,MoS2@ZnxCd1-xS是以固溶体形式存在,并非简单地物理混合.随后HRTEM进一步证实所形成的固溶体催化剂呈六方晶相.采用XPS和Raman分析了元素的化学环境,发现固溶体与MoS2可能是通过Mo-S-Cd/Zn键而结合;而MoS2表现出1-T与2-H的混相结构.材料的吸光性能通过紫外可见漫反射测试.我们发现,随着ZnS含量的不断增加,固溶体在可见光区域的吸收不断减弱,同时吸收带边向着紫外光区移动.而光催化制氢性能测试实验表明,Zn0.5Cd0.5S体系呈现出最佳的性能,这可能是因为当Cd:Zn=1:1时,固溶体策略对于CdS在热力学与动力学方面的提升均达到最佳.而MoS2量的增加,产氢效果也呈现出“火山峰”似的规律,过多的MoS2将会吸收主要的入射光,从而使Zn0.5Cd0.5S不能被有效地激发进而参与到反应中去.液相色谱-质谱联用技术表明阿莫西林的降解不仅仅是由于吸附所致,光催化也存在一定的贡献.而反应前后的XRD与XPS结果则表明了催化剂结构稳定.     

Efficient synthesis of enantiomeric pairs of thiolactomycin and its 3-demethyl derivative

Starting with commercially available tiglic aldehyde, the title synthesis was achieved by employing deconjugative asymmetric α-sulfenylation of the chiral 3-(α,β,γ,δ-unsaturated acyl)-2-oxazolidinone with a methanethiosulfonate as a key step.     

Total synthesis of the antibiotic 4-hydroxycyclopent-2-en-1-one acrylate derivative EA-2801

The first total synthesis of (±)-EA-2801, a naturally occurring 4-hydroxycyclopent-2-en-1-one acrylate produced by the fungus Trichoderma atroviridae UB-LMA, was achieved The synthesis started from furfuryl alcohol, manufactured industrially from furfural, produced from waste biomass such as corncobs or sugar cane bagasse. (±)-EA-2801 was synthesized in 5 steps and 71% overall yield starting from 4-hydroxycyclopent-2-en-1-one. Enantio-pure (R)- and (S)-EA-2801 were obtained from racemic mixture by preparative chiral supercritical fluid chromatography (SFC).     

Process optimization and kinetics study for photocatalytic ciprofloxacin degradation using TiO2 nanoparticle: A comparative study of Artificial Neural Network and Surface Response Methodology

The photocatalytic degradation of ciprofloxacin was investigated by developing a predictive mathematical model using response surface methodology and an artificial neural network. The four independent variables involve solution pH, reaction time, catalyst dose, and initial antibiotic concentration considered as factors in central composite design to observe the response in the form of antibiotic degradation. Accordingly, at an optimum antibiotic concentration of 5.02 mg/L, catalyst dose of 44.51 mg/L, solution pH of 5.04, and reaction time of 75.80 min, the photocatalysis method achieved a ciprofloxacin degradation of 88.30%. The experimental outputs were very much consistent along with the predicted output of experiments through response surface methodology (R² = 0.9969) and artificial neural network (R² = 0.975). The adsorption isotherm and kinetic study reveal that Langmuir isotherm and pseudo-second-order kinetic models respectively were best fitted for degradation of ciprofloxacin through photocatalysis. The finding provides a novel method for evaluating the photocatalysis process for the optimization of ciprofloxacin antibiotic removal from pharmaceutical waste using experiments and computer simulation tools.     

Poly(acrylamide-co-itaconic acid) as a Potential Ion-Exchange Sorbent for Effective Removal of Antibiotic Drug-Ciprofloxacin from Aqueous Solution

This study describes equilibrium and kinetic sorption studies to remove the antibiotic drug Ciprofloxacin (CF) from aqueous solutions using poly(acrylamide-co-itaconic acid) [poly(AAm-co-IA)] as polymeric cation exchanger sorbent material. The co-polymeric sorbent was prepared by free radical induced aqueous polymerization and was characterized by FTIR spectroscopy and TGA analysis. In addition, its physicochemical parameters were also determined. The various isotherm models, when applied to equilibrium sorption data at 28°C, followed the following order: Langmuir > Temkin > Freundlich, with the fair maximum sorption capacity (Q _o ) of 178.5 mg g^?1. The kinetic sorption data, obtained at 28°C, was applied to kinetic models such as pseudo first order equation, pseudo second order model and a simple Elovich model. Based on regression values, the order of fitness of these models was pseudo second order > pseudo first order > simple Elovich model. The second order adsorption coefficients k_2adswere found to be 58 × 10^?3, 52.7 × 10^?3, 34.01×10^?3 g/mg min for drug solutions with initial concentrations of 10, 20 and 30 mg L^?1 respectively The sorption mean free energy from the Dubinin–Raduschkevich (DR) isotherm was found to be nearly 8.839 kJ mol^?1 indicating an ion-exchange mechanism for drug uptake. The optimum pH value of sorbate solution for drug uptake was found to be around 6.0. Finally, the antibacterial action of drug was investigated and it was found that after adsorption there was a decrease in bacterial growth inhibition efficiency of drug solution.     

Aglycon switch approach toward unnatural glycosides from natural glycoside with glycosyltransferase VinC

New aglycon switch approach using glycosyltransferase VinC was explored to create unnatural glycosides from natural glycoside in one-pot reaction. This aglycon switch comprises from two reactions, where NDP-vicenisamine generated in situ from natural glycoside vicenistatin and NDP by the reverse reaction is transferred to the targeted additional aglycons to form unnatural vicenisaminides by the forward reaction.     

Stereoselective intramolecular hetero Diels-Alder reactions of 1-oxa-1,3-butadienes: synthesis of novel annelated pyrrolo[1,2-a]indoles

Novel classes of pyrano-1,3-dioxane-, pyranopyrimidine- and pyranopyrazole-fused pyrrolo[1,2-a]indoles are synthesised via stereoselective intramolecular 1-oxa-1,3-butadiene hetero Diels-Alder reactions.     

A highly efficient, asymmetric synthesis of blastidic acid: the β-amino acid component of the antibiotic, (+)-blasticidin S

A new approach for the asymmetric synthesis of blastidic acid, the β-amino acid component of the antibiotic, (+)-blasticidin S has been achieved in 11 steps and 30% overall yield. The key transformations involve a one-pot Swern/Wittig reaction sequence to prepare the carbon backbone followed by a stereoselective conjugate addition to introduce the β-amino functionality.